Zion Market Research Global Urinary Tract Cancer Market, 2015–2021 | Page 3

Urinary Tract Cancer Market
Increasing consumption of cigarettes globally coupled with increasing sedentary lifestyle
had increased the incidence of urinary tract cancer. Accomplishment from the government
to generate awareness regarding the urinary tract cancer and advance modern medications
drives the urinary tract cancer market. Lack of awareness in the developing countries may
suppress the growth of urinary tract cancer market. Nevertheless, untapped techniques for
treatment of urinary tract cancer are likely to open new opportunities for the urinary tract
cancer market in the coming years.
Request Report TOC (Table of Contents) @
https://www.zionmarketresearch.com/toc/urinary-tract-cancer-market
Based on type the urinary tract cancer market can be segmented as squamous cell
carcinoma, adenocarcinoma and urothelial carcinoma among others. Urothelial carcinoma is
leading segment with 95% of incidence rate, globally. On basis of diagnostic techniques, the
urinary tract cancer market is segmented into, cystoscopy, transurethral resection of tumor,
imaging tests and urine analyses among others. Different treatments for the urinary tract
cancer include chemotherapy, intravesical therapy, radiation therapy, and surgery.
North America and Europe dominated the urinary tract cancer market owing to high
prevalence rate of urinary tract cancer, increasing healthcare expenditure and sophisticated
healthcare sector. Asia Pacific is expected to experience fastest growth in the forecast
period. Factors such as increasing awareness, growing healthcare sector and rising
government support for research and development are the driving factors for the urinary
tract cancer market in these region.